DERMABOND (A FORMULATION OF 2-OCTYL CYANOACRYLATE)

FDA Premarket Approval P960052

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

This device is indicated for topical application to hold closed easily approximated skin edges from surgical incisions, including punctures from minimally invasive surgery, and simple, thoroughly cleansed, trauma-induced lacerations. Dermabond(tm) may be used in conjunction with, but not in place of, subcuticular sutures.

DeviceDERMABOND (A FORMULATION OF 2-OCTYL CYANOACRYLATE)
Generic NameTissue Adhesive For The Topical Approximation Of Skin
ApplicantCLOSURE MEDICAL CORP.
Date Received1996-12-24
Decision Date1998-08-26
Notice Date1998-10-27
PMAP960052
SupplementS
Product CodeMPN 
Docket Number98M-0879
Advisory CommitteeGeneral & Plastic Surgery
Expedited ReviewYes
Combination Product No
Applicant Address CLOSURE MEDICAL CORP. 5265 Capital Blvd. raleigh, NC 27616
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P960052Original Filing
S012 2006-08-16 30-day Notice
S011 2005-12-16 Real-time Process
S010 2005-02-09 Real-time Process
S009 2004-08-19 Normal 180 Day Track No User Fee
S008
S007 2003-10-09 Special (immediate Track)
S006 2003-05-01 Real-time Process
S005 2002-06-27 Special (immediate Track)
S004 2001-05-01 Normal 180 Day Track
S003 2001-04-10 Normal 180 Day Track
S002 2001-03-12 Special (immediate Track)
S001 1999-06-09 Special (immediate Track)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.